Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor

NCT01166477 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

228

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Lopinavir and ritonavir
DRUG: Triple therapy with ritonavir

Sponsor

Sociedad Andaluza de Enfermedades Infecciosas